Diabetes found is not followed.
The AI care agent for diabetes
Screening finds the people. Keeping them well takes years of care, for more people than any health system has hands for. Laterpath does that work for a whole population, every week, in English, Arabic and Spanish, so your clinicians make the decisions and no one is lost to follow-up.
The crisis
Nearly one adult in nine. Four in ten of them don't know.
589 million adults have diabetes; 252 million have not been diagnosed.
Behind every number is a person, and a health system doing all it can.
What it costs people
Sight
1.07 million2
people blind from diabetic eye disease, and 3.28 million more with serious sight loss (2020)
A foot
18.6 million3
people get a diabetic foot ulcer each year; ulcers come before 80% of diabetes-related amputations
A kidney
47%4
of new kidney failure in the United States is caused by diabetes (2019)
Three in four adults with diabetes live in low- and middle-income countries. Blindness, kidney failure and amputation build over years, and many begin with something small: a retest that is overdue, a result still waiting to be read, a foot problem not yet mentioned. With so many people to look after, small things are hard to catch in time.
People living with diabetes:
Too many people. Too few hands. Now there's help.
Laterpath Care Agent
Laterpath does the chasing. Your clinicians decide.
Each night, or on demand, Laterpath reviews every person in a program, decides what each one needs, does the routine work itself and prepares the rest for a clinician's one-click decision. Every action is logged with the numbers it relied on and a one-line reason.
The cycle, every night
Review
Reads each person's latest readings, lab results, stage and foot records.
Decide
Picks what each person needs now, using the program's rules.
Act
Does the routine work itself, prepares what needs approval, and never takes a forbidden step.
Follow up
Checks whether it worked, such as a reading arriving or a test being done, and adapts with smaller steps, never louder ones.
Report
Writes a plain-language summary: what changed, who needs a human, what it did and why.
Safety net for readings
An urgent glucose or blood-pressure reading, or a red-flag symptom, goes straight to the top of the clinician queue. In the app, the person sees at once what to do now, including the emergency number.
New-diabetes fast track
A first HbA1c of 6.5% or above starts a repeat test, a booking request and a doctor's letter, prepared for one-click approval.
No result left behind
Every lab result is tracked until a clinician has seen it. For people with diabetes, overdue HbA1c, cholesterol and kidney tests are chased; unseen abnormal results are escalated.
Foot protection pathway
The yearly foot check for people with diabetes, tracked and chased with the care team. A high-risk result becomes a consented referral to podiatry or a wound-care partner, followed to the outcome.
Care-gap closer
Missing regular checks for people with diabetes (eye, kidney, foot, HbA1c, cholesterol, blood pressure) found and chased until each is closed.
Visit brief and program report
One page per appointment: what changed, the gaps, an agenda. A monthly program report in English, formal Arabic or Spanish, approved before release.
Three classes of action
Autonomous
- Examples
- Encouragement and next-step messages in the person's language, reminders, lab-test-due reminders, easier steps, weekly summaries.
- Who acts
- The AI, within frequency caps and quiet hours.
Needs approval
- Examples
- Escalation to a clinician, referral to a wound-care partner with the person's consent, a doctor's letter, outreach by the care team.
- Who acts
- The AI prepares; a named person approves or edits with one click.
Never
- Examples
- Starting, stopping or changing any medicine. Making a diagnosis. Any number the engine did not compute.
- Who acts
- No one: blocked by guardrails, and every attempt is logged.
| Class | Examples | Who acts |
|---|---|---|
| Autonomous | Encouragement and next-step messages in the person's language, reminders, lab-test-due reminders, easier steps, weekly summaries. | The AI, within frequency caps and quiet hours. |
| Needs approval | Escalation to a clinician, referral to a wound-care partner with the person's consent, a doctor's letter, outreach by the care team. | The AI prepares; a named person approves or edits with one click. |
| Never | Starting, stopping or changing any medicine. Making a diagnosis. Any number the engine did not compute. | No one: blocked by guardrails, and every attempt is logged. |
Built for supervision
An approval queue, a pause switch, a spending cap and a full audit trail.
Built for scale
A full population review each night. Measured AI cost: under 3 US cents per person per review.†
Built for people
A friendly advisor, not an authority. Gulf Arabic, large text, right-to-left, and "Why did I get this?" behind every message.
How it helps
Know the date. Then move it.
Four steps, from the first raised reading to looking after your feet.
1. Your stage
Spot it early
Your everyday numbers place you on a simple 10-step scale. Laterpath shows when you may reach the diabetes range, often years ahead, while there is still time to change it.
2. Your plan
Slow it down
A plan that fits your life: simple, practical steps aimed at the numbers that matter most for you. Laterpath also shows when your next lab test is due. Laterpath checks in, gently, and makes the step smaller if it isn't working.
3. Foot checks
Protect your feet
Diabetes can quietly damage the nerves and blood flow in your feet. Your care team records a foot check each year, and if the risk is high, Laterpath prepares a referral to a foot specialist with your consent.
4. Your record
See your progress
Every reading and every step adds up to one clear record. Download it and take it to your doctor, so you can both see the date moving the right way.
Four simple numbers
- Blood sugar
- Waist
- Weight
- Blood pressure
Try it
Change one number. Watch the date move.
This is a made-up example: a person whose numbers have crept up slowly over two years. Move the slider to change their waist size, and see how much sooner — or later — trouble could arrive.
Today: stage 3 of 10
Example only- Past readings
- Where it's heading
- When it crosses the line
- Diabetes range
- Nerve, circulation and foot problems
Reaches the diabetes range
around Dec 2028
No change from the start
Nerve, circulation and foot problems
not in the next 10 years
This is an example, not a prediction about you, and not medical advice.
For organizations
For the people who answer for a population.
Health systems, hospitals, insurers, employers and ministries. Offer Laterpath to the people you look after and let the Care Agent carry the follow-up.
Who needs help first
A list of who needs a clinician first, with the most urgent at the top, so your care team reaches the right people first.
A letter for the doctor
A one-page letter for a member's doctor when a review is needed, with the readings behind it.
Group dashboards
See how your whole population is doing over time. Groups smaller than five are not shown, so no one can be singled out.
Monthly report in English, Arabic and Spanish
What changed, who needs a human, gaps closed, estimated staff hours saved. Approved by a named person before anyone sees it.
Clinician in control
An approval queue grouped by person, a pause switch for the whole program and a spending cap on every run.
Your brand
Your name, colors and logo on the app and the reports.
Works with health records
Lab results in from your laboratory or EHR with HL7 FHIR (arriving now). NPHIES in Saudi Arabia is planned.
English, Arabic and Spanish
The app and reports in all three languages, with Arabic reading right to left.
Data stays where it should
Hosting in your region is planned with each partner, so members' information stays where the rules say it must.
We are choosing our first pilot partners now. Pilots are 90 days, supervised, with measures agreed in advance.Talk to us about a pilot
Where we work
Three languages. One standard of care.
The Gulf
Arabic and English, with Arabic reading right to left. In-region hosting and NPHIES are planned with each partner.
Southeast Asia
Malaysia, in English, with personal data handled under the PDPA.
The United Kingdom
English, for the NHS in England and Scotland. UK GDPR data rights; the NHS Data Security and Protection Toolkit is planned with each partner.
The United States
English and Spanish, HIPAA safeguards, and lab import with HL7 FHIR arriving.
Lab tests
Your tests, in plain words.
Your blood test results don't sit in a PDF. They join your everyday numbers on one simple line.
HbA1c — the number that matters most
HbA1c shows your average blood sugar over about three months. It's the main test doctors use for diabetes, and Laterpath follows it test after test.
See when your next test is due
Laterpath shows which test is due next, so you never lose track of when to go back.
Easy to add
Upload a PDF of your lab report and the results are read for you, or attach a photo. Results sent straight from your clinic are arriving (HL7 FHIR).
More than 40 common tests
From blood sugar and cholesterol to kidney, liver and thyroid. Each one is compared with your own lab's normal range.
Glucose sensors
Import a file from Dexcom Clarity. LibreView import is planned.
Device connections (Apple Health, Google Fit, Samsung Health, Withings, Omron) and live links to glucose sensors are planned. Today you type in your other readings; it takes a few seconds.
Is it safe?
What we know. What we don't yet.
You should know exactly what Laterpath is — and what it isn't.
The Care Agent has not yet been measured in a clinic
It runs today on a demonstration population of made-up people. Its effect on outcomes will come from a supervised pilot, and we will publish what we find.
Our own scale, still being tested
Laterpath's 10-stage scale is our own, built on published medical research. We are checking it against real results. Until that work is published, please treat every date as an estimate.
Clinicians decide
A named doctor or nurse approves every referral, doctor's letter and escalation before it goes anywhere. Urgent readings go straight to the top of the clinician queue.
Not a diagnosis
Laterpath shows which way your numbers are heading, and roughly when. It does not diagnose diabetes or any other condition, and it never replaces your doctor.
Your information is protected
Built with HIPAA's safeguards: encryption, access logs, and your right to see, download or delete your information.
Why we built it
Simon Lee
Founder & President
30+Years in health technology
21+Countries
I've spent more than 30 years in health technology, in 21 countries. In country after country I watched diabetes grow faster than any health system could grow to meet it: more people every year, each needing years of care. Too often the lost sight, the amputation and the dialysis chair follow from that gap between how many people need help and how many hands there are to give it. Today's technology can finally carry the heavy lifting, so clinicians can give their time where only they can. I built Laterpath so that no one who has been found is then lost.
Articles
Plain-language reading about blood sugar, blood pressure and staying well.
- Metabolic Health
What Is Metabolic Health and Why Should You Care?
Metabolic health affects every system in your body. Learn what it means, why 90% of adults are at risk, and what you can do about it today.
Read the article - Disease Prevention
Understanding Insulin Resistance: The Silent First Step Toward Chronic Disease
Insulin resistance is the earliest stage of metabolic decline, but it's also the most reversible. Here's what you need to know.
Read the article - Biomarker Tracking
A Complete Guide to Blood Pressure Monitoring at Home
Home blood pressure monitoring gives you better data than occasional clinic visits. Learn how to do it right and what your numbers mean.
Read the article
Contact
Talk to us.
Laterpath is by invitation for now. Tell us a little about yourself and we'll get back to you.
Which describes you?
Mention it in your message.
Ask your employer, insurer or clinic if they offer Laterpath. Or tell us you're interested.
Pilots for your staff or members, with clear reports on results.
Clinician review is built in, and lab import with HL7 FHIR is arriving. Tell us what you need.
Sources
- 1.International Diabetes Federation. IDF Diabetes Atlas, 11th edition, 2025. News release “Over 250 million people worldwide unaware they have diabetes”, 7 April 2025. idf.org (opens in a new tab)
- 2.GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group. “Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 2000 to 2020.” Eye, 2024. pmc.ncbi.nlm.nih.gov (opens in a new tab)
- 3.Armstrong DG, Tan TW, Boulton AJM, Bus SA. “Diabetic Foot Ulcers: A Review.” JAMA. 2023;330(1):62–75. doi:10.1001/jama.2023.10578. pubmed.ncbi.nlm.nih.gov (opens in a new tab)
- 4.Burrows NR, Koyama A, Pavkov ME. “Reported Cases of End-Stage Kidney Disease — United States, 2000–2019.” MMWR. 2022;71(11):412–415. doi:10.15585/mmwr.mm7111a3. cdc.gov (opens in a new tab)
- 5.Centers for Disease Control and Prevention. National Diabetes Statistics Report, updated 16 September 2026 (2023 data). cdc.gov (opens in a new tab)
- 6.Diabetes UK. “How many people in the UK have diabetes?” (over 4.7 million diagnosed, 2024–25, and almost 1.3 million undiagnosed). diabetes.org.uk (opens in a new tab)
- 7.Scottish Diabetes Group. Scottish Diabetes Survey 2025 (end of 2025). diabetesinscotland.org.uk (opens in a new tab)
- 8.International Diabetes Federation. IDF Diabetes Atlas 2025: Saudi Arabia (adults 20–79, 2024). diabetesatlas.org (opens in a new tab)
- 9.Institute for Public Health, Ministry of Health Malaysia. National Health and Morbidity Survey 2023: Key Findings, 2024 (15.6% of adults). iku.nih.gov.my (opens in a new tab) Count as reported by CodeBlue, “Over Two Million Adults In Malaysia Live With Three NCDs: NHMS 2023”, 28 May 2024. codeblue.galencentre.org (opens in a new tab)
- 10.International Diabetes Federation. IDF Diabetes Atlas 2025: United Arab Emirates (adults 20–79, 2024). diabetesatlas.org (opens in a new tab)
- Under 3 US cents per person per review: Laterpath measurement on demonstration data (US$2.06 for 280 people).